CTSU Logo
CTSU Logo Home | Contact | FAQ | CTSU Members Site  
CTSU Logo
Patients PagePhysicians PageNon-Group Investigators PageInformation for Canadian SitesRSS PageCTSU eCourseRelated links to the CTSU project and cancer issues.CTSU Registration Process
 Welcome to the CTSU Public Web Site
 GENERAL INFORMATION

- Register for access to CTSU

 PRESS RELEASES

- Cancer Drug Gleevec Improves Recurrence-Free Survival after Surgery for Patients with Primary Gastrointestinal Stromal Tumor

- Personalized Treatment Trial for Breast Cancer Launched

- CTSU Menu Trials Included in Medicare Pilot

- Bevacizumab Combined With Chemotherapy Improves...

- Bevacizumab Combined With Chemotherapy Prolongs Survival...  

- ECOG Trial Prolongs Survival for Patients With Colorectal Cancer 

 PRESENTATIONS

CTSU Overview Presentation (10/2/07)

  • PDF Version
  • Text only version


  •  GUIDES and TRAINING

    - CTSU Process Checklist

    - On-Line Education for the Public and Patients

    - On-Line Training/Education for Healthcare Professionals

    - CIRB (Central Institutional Review Board)

    - CIRB - Approved Protocols
    (for Participating Institutions)


    - Informed Consent Information

     OTHER LINKS

    - NCI Hurricane Response Efforts

    - NCI-CTEP Relationship

    - Events

    - CTSU Web Site Accessibility


    spacer  A CTSU TESTIMONIAL spacer
    photo of Alan P. Lyss, M.D. "I think that many investigators, clinical research professionals, and research nurses were apprehensive about how the CTSU would add value to their research programs. At our program, we maintain a regular watch on the CTSU menu of protocols. When a gap has developed in the protocols that are available through our major cooperative group, CALGB, we have opened CTSU studies, particularly when the gap involves a quantitatively large segment of our referrals. The CTSU has enabled us to offer those patients high quality, NCI-sponsored studies and maintain our high accrual standards, during what previously was "down time" for our research office."
    Alan P. Lyss, M.D.
    Director, Cancer Center and Clinical Research
    Missouri Baptist Medical Center


    [Testimonials Archive]

    Spacer  ABOUT THE CTSU Spacer
    The Cancer Trials Support Unit (CTSU) is a project sponsored by the National Cancer Institute (NCI) for the support of a national network of physicians to participate in NCI-sponsored Phase III cancer treatment trials. The majority of these trials are sponsored by the adult Cooperative Clinical Trials Groups listed here.

      ACOSOG - (American College of Surgeons Oncology Group)

      CALGB - (Cancer and Leukemia Group B)

      ECOG - (Eastern Cooperative Oncology Group)

      GOG - (Gynecologic Oncology Group)

      NCIC CTG - (National Cancer Institute of Canada Clinical Trials Group)

      NCCTG - (North Central Cancer Treatment Group)

      NSABP - (National Surgical Adjuvant Breast and Bowel Project)

      RTOG - (Radiation Therapy Oncology Group)

      SWOG - (Southwest Oncology Group)


    CTSU Objectives:
  • Increase physician and patient access to NCI-sponsored clinical trials
  • Streamline and standardize trial data collection and reporting
  • Reduce regulatory/administrative burden on investigators participating in NCI-sponsored Cooperative Group clinical trials (phases 1-3)
  • PLEASE NOTE: Cooperative Group sites located within the United States and Canada are currently eligible for participation in the CTSU. In addition, the CTSU is now open to physicians and institutions in the United States who are not affiliated with a Cooperative Group. Click on the tab for Non-Group Investigators for more information.
     CTSU PROTOCOLS

    Here you'll find...
  • Protocol title and abstract
  • Eligibility Checklist & Schema
  • Physician Fact Sheets
  • PowerPoint Presentations
          (where available)
  • Accrual Information







    To search for other cancer protocols, please visit the NCI Cancer.gov web site.
  •  REPORTS
    CTSU Active Protocol List & Accrual Report:
  • by Cancer Type
  • by Cooperative Group
  • by Protocol Number


    Disclaimer - The CTSU does not itself provide treatment information to individual patients or their families. For assistance with finding answers to your cancer-related questions, we encourage you to contact the National Cancer Institute's Cancer Information Service (CIS) for personal, confidential help. The CIS is the source for the latest, most accurate cancer information for patients, their families, the general public, and health professionals. To talk with an information specialist, please call 1–800–4–CANCER (1–800–422–6237). For callers with TTY equipment, the number is 1–800–332–8615. CIS information specialists also offer live, online assistance through the LiveHelp® link on the NCI’s Web site (click on “LiveHelp online chat”) or at https://cissecure.nci.nih.gov/livehelp/welcome.asp" on the Internet.
    Read more...